Patients with breast tumors expressing high levels of FOXO3 protein had better MFS than patients with breast tumors expressing lower levels of FOXO3 protein (p = 4.1.10−2), which is consistent with a tumor suppressor role (Fig. 2A). Here, FOXO3 is linked to neoplasm.